159 related articles for article (PubMed ID: 8945683)
1. Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes.
Corsini A; Bonfatti M; Quarato P; Accomazzo MR; Raiteri M; Sartani A; Testa R; Nicosia S; Paoletti R; Fumagalli R
J Cardiovasc Pharmacol; 1996 Nov; 28(5):687-94. PubMed ID: 8945683
[TBL] [Abstract][Full Text] [Related]
2. The new calcium antagonist lercanidipine and its enantiomers affect major processes of atherogenesis in vitro: is calcium entry involved?
Corsini A; Accomazzo MR; Canavesi M; Sartani A; Testa R; Catapano AL; Fumagalli R; Paoletti R; Bernini F
Blood Press Suppl; 1998; 2():18-22. PubMed ID: 9850438
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
4. Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites.
Okumura K; Ichihara K; Nagasaka M; Oda N; Tajima K
Eur J Pharmacol; 1993 Apr; 235(1):69-74. PubMed ID: 8519282
[TBL] [Abstract][Full Text] [Related]
5. Activity of dihydrothienopyridine S312 enantiomers on L-type Ca2+ channels in isolated rat aorta and cerebral microvessels.
Dessy C; Salomone S; Morel N; Godfraind T
Eur J Pharmacol; 1993 Feb; 231(3):435-42. PubMed ID: 8449235
[TBL] [Abstract][Full Text] [Related]
6. Lercanidipine and T-type calcium current.
Cerbai E; Mugelli A
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):4025-4031. PubMed ID: 29949180
[TBL] [Abstract][Full Text] [Related]
7. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling.
Wu JR; Liou SF; Lin SW; Chai CY; Dai ZK; Liang JC; Chen IJ; Yeh JL
Pharmacol Res; 2009 Jan; 59(1):48-56. PubMed ID: 18973813
[TBL] [Abstract][Full Text] [Related]
8. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues.
Angelico P; Guarneri L; Leonardi A; Testa R
J Pharm Pharmacol; 1999 Jun; 51(6):709-14. PubMed ID: 10454048
[TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic acid inhibits vasopressin-activated Ca2+ influx and cell proliferation in rat aortic smooth muscle cell lines.
Asano M; Nakajima T; Iwasawa K; Asakura Y; Morita T; Nakamura F; Tomaru T; Wang Y; Goto A; Toyo-oka T; Soma M; Suzuki S; Okuda Y
Eur J Pharmacol; 1999 Aug; 379(2-3):199-209. PubMed ID: 10497907
[TBL] [Abstract][Full Text] [Related]
10. In vitro calcium antagonistic and antioxidant effects of Org 13061 and its enantiomers, new potential antiatherosclerotic compounds.
Beaughard M; Chevalier A; Dureng G; Leboeuf J; Massingham R; Mazur A; Rayssiguier Y; Winslow E
Fundam Clin Pharmacol; 1997; 11(5):416-26. PubMed ID: 9342595
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of L-type Ca2+ channels in portal vein myocytes by the enantiomers of oxodipine.
Baron A; Rakotoarisoa L; Leprêtre N; Mironneau J
Eur J Pharmacol; 1994 Sep; 269(1):105-13. PubMed ID: 7828652
[TBL] [Abstract][Full Text] [Related]
12. Ca2+ channel inhibition by a new dihydropyridine derivative, S11568, and its enantiomers S12967 and S12968.
Randle JC; Lombet A; Nagel N; Abraham C; Aptel H; Peglion JL; Renaud JF
Eur J Pharmacol; 1990 Nov; 190(1-2):85-96. PubMed ID: 1706275
[TBL] [Abstract][Full Text] [Related]
13. NZ-105, a new 1,4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta.
Yamashita T; Masuda Y; Sakai T; Tanaka S; Kasuya Y
Jpn J Pharmacol; 1991 Nov; 57(3):337-48. PubMed ID: 1667534
[TBL] [Abstract][Full Text] [Related]
14. Effects of manidipine and nitrendipine enantiomers on the plateau phase of K+-induced intracellular Ca2+ increase in GH3 cells.
Cataldi M; Taglialatela M; Palagiano F; Secondo A; de Caprariis P; Amoroso S; di Renzo G; Annunziato L
Eur J Pharmacol; 1999 Jul; 376(1-2):169-78. PubMed ID: 10440102
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative effects of benidipine hydrochloride in porcine cultured vascular smooth muscle cells and in rats subjected to balloon catheter-induced endothelial denudation.
Ide S; Kondoh M; Satoh H; Karasawa A
Biol Pharm Bull; 1994 May; 17(5):627-31. PubMed ID: 7920421
[TBL] [Abstract][Full Text] [Related]
16. Effect of the nifedipine-atenolol association on arterial myocyte migration and proliferation.
Corsini A; Quarato P; Raiteri M; Paubert-Braquet M; Nguyen G; Picquot S; Bourgain RH; Fumagalli R; Paoletti R
Pharmacol Res; 1993; 27(4):299-307. PubMed ID: 8367379
[TBL] [Abstract][Full Text] [Related]
17. Ca2+ channels in chick neural retina cells characterized by 1,4-dihydropyridine antagonists and activators.
Wei XY; Rutledge A; Zhong Q; Ferrante J; Triggle DJ
Can J Physiol Pharmacol; 1989 May; 67(5):506-14. PubMed ID: 2548693
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of vascular relaxation by thaligrisine: functional and binding assays.
Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E
Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849
[TBL] [Abstract][Full Text] [Related]
19. cAMP signaling inhibits dihydropyridine-sensitive Ca2+ influx in vascular smooth muscle cells.
Orlov SN; Tremblay J; Hamet P
Hypertension; 1996 Mar; 27(3 Pt 2):774-80. PubMed ID: 8613239
[TBL] [Abstract][Full Text] [Related]
20. Effect of S-312, a new calcium channel blocker, on the 1,4-dihydropyridine binding sites in porcine basilar blood vessels and rat aortic smooth muscle cells.
Mihara S; Fujimoto M
Jpn J Pharmacol; 1991 Jul; 56(3):249-59. PubMed ID: 1832726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
